1. Home
  2. ABCL vs STEP Comparison

ABCL vs STEP Comparison

Compare ABCL & STEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$13.27

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

STEP

StepStone Group Inc.

HOLD

Current Price

$45.00

Market Cap

3.9B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABCL
STEP
Founded
2012
2007
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
3.9B
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
ABCL
STEP
Price
$13.27
$45.00
Analyst Decision
Strong Buy
Buy
Analyst Count
11
9
Target Price
$16.70
★ $69.56
AVG Volume (30 Days)
★ 4.4M
931.3K
Earning Date
11-09-2026
11-05-2026
Dividend Yield
N/A
★ 4.13%
EPS Growth
★ 10.91
N/A
EPS
★ N/A
N/A
Revenue
$75,128,000.00
★ $1,993,603,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$7.91
$17.50
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 160.56
69.69
52 Week Low
$2.75
$38.85
52 Week High
$14.98
$77.80

Technical Indicators

Market Signals
Indicator
ABCL
STEP
Relative Strength Index (RSI) 59.09 43.76
Support Level $10.38 $44.48
Resistance Level N/A $46.56
Average True Range (ATR) 0.77 1.83
MACD 0.05 -0.32
Stochastic Oscillator 58.85 27.63

Price Performance

Historical Comparison
ABCL
STEP

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

About STEP StepStone Group Inc.

StepStone Group Inc operates as a fully integrated private markets solution provider. The company provides customized investment solutions and advisory and data services. It provides investment solutions in the areas of private equity, real estate, private debt, and infrastructure and real assets. The company consists of a single operating segment and a single reportable segment for accounting and financial reporting purposes.

Share on Social Networks: